In August 2025, China’s Vitamin D3 market experienced a pronounced downturn driven by subdued domestic and international demand alongside elevated inventory levels. Stable production and uninterrupted logistics sustained supply, but cautious buyer sentiment and preference for spot purchases suppressed transaction volumes. Export activity weakened due to global trade uncertainty and extended U.S.-China tariff truce, further dampening overseas orders. Suppliers accelerated stock clearance amid regional disruptions, offering discounts to stimulate sales. With muted demand and persistent oversupply, bearish market conditions prevailed, exerting downward pressure on prices expected to continue in the coming months.
Key Highlights
-
The sluggish demand for Vitamin Dx persisted through August xxxx, with cautious buying sentiment from buyers, and stable domestic production.
-
High inventory and declining global orders, especially from the U.S., were significant factors that continued to diminish Vitamin Dx prices.
-
Suppliers ramped up clearing Vitamin Dx stock by offering discounts, compounded by flooding and monsoon disruptions in the area.
-
International demand for Vitamin Dx fell rapidly after the U.S.-China trade truce was extended, resulting in less effort to buy the product overseas.
-
Even with uninterrupted logistics and customs throughput, the oversupply situation persisted and figured in overall weak Vitamin Dx market sentiment.
On the demand side, Vitamin Dx witnessed subdued demand throughout August xxxx. This is driven by tepid consumption and ample supply. Domestic production of Vitamin Dx remained stable, but the transaction volumes...
